BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 12797691)

  • 1. Is the DOTS strategy sufficient to achieve tuberculosis control in low- and middle-income countries? 1. Need for interventions in universities and medical schools.
    Caminero JA
    Int J Tuberc Lung Dis; 2003 Jun; 7(6):509-15. PubMed ID: 12797691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is the DOTS strategy sufficient to achieve tuberculosis control in low- and middle-income countries? 2. Need for interventions among private physicians, medical specialists and scientific societies.
    Caminero JA
    Int J Tuberc Lung Dis; 2003 Jul; 7(7):623-30. PubMed ID: 12870682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [How to cope with the global tuberculosis burden--experiences and perspectives for Japan's international cooperation].
    Ishikawa N
    Kekkaku; 2005 Feb; 80(2):89-94. PubMed ID: 15920981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DOTS implementation in a middle-income country: development and evaluation of a novel approach.
    Vaca J; Peralta H; Gresely L; Cordova R; Kuffo D; Romero E; Tannenbaum TN; Houston S; Graham B; Hernandez L; Menzies D
    Int J Tuberc Lung Dis; 2005 May; 9(5):521-7. PubMed ID: 15875923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tuberculosis control: current status, challenges and barriers ahead in 22 high endemic countries.
    Ibrahim KM; Khan S; Laaser U
    J Ayub Med Coll Abbottabad; 2002; 14(4):11-5. PubMed ID: 12688094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of different treatment strategies for tuberculosis in Egypt and Syria.
    Vassall A; Bagdadi S; Bashour H; Zaher H; Maaren PV
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1083-90. PubMed ID: 12546116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Reform of Japan's NTP and its technical perspectives].
    Mori T
    Kekkaku; 2004 Oct; 79(10):587-604. PubMed ID: 15631111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Working towards TB elimination the WHO Regional Strategic Plan (2006-2015).
    Nair N; Cooreman E
    J Commun Dis; 2006 Mar; 38(3):185-90. PubMed ID: 17373351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beyond DOtS: avenues ahead in the management of tuberculosis.
    Chaudhury RR; Thatte U
    Natl Med J India; 2003; 16(6):321-7. PubMed ID: 14765625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Tuberculosis and its control--lessons from the past and future prospect].
    Shimao T
    Kekkaku; 2005 Jun; 80(6):481-9. PubMed ID: 16130906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Development and perspectives of community DOTS].
    Narita T; Kobayashi N
    Kekkaku; 2009 Apr; 84(4):187-201. PubMed ID: 19425394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DOTS in China - removing barriers or moving barriers?
    Xu B; Dong HJ; Zhao Q; Bogg L
    Health Policy Plan; 2006 Sep; 21(5):365-72. PubMed ID: 16940302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of tuberculosis in the Americas: the Stop TB strategy and the millennium development goals.
    Ramon-Pardo P; Del Granado M; Gerger A; Canela Soler J; Mir M; Armengol R; Lopez Olarte RA; Rodriguez R
    Int J Tuberc Lung Dis; 2009 Aug; 13(8):969-75. PubMed ID: 19723376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The importance of the examination of, education on, and infection control of tuberculosis in medical school hospitals in Japan].
    Kurane S; Kudoh S
    Kekkaku; 2003 Sep; 78(9):573-80. PubMed ID: 14577343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Human resource capacity building on TB laboratory work for TB control program--through the experience of international TB laboratory training course for TB control at the Research Institute of Tuberculosis, JATA, Japan].
    Fujiki A; Kato S
    Kekkaku; 2008 Jun; 83(6):475-9. PubMed ID: 18634453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global investments in TB control: economic benefits.
    Laxminarayan R; Klein EY; Darley S; Adeyi O
    Health Aff (Millwood); 2009; 28(4):w730-42. PubMed ID: 19567413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic evaluation of public-private mix for tuberculosis care and control, India. Part II. Cost and cost-effectiveness.
    Pantoja A; Lönnroth K; Lal SS; Chauhan LS; Uplekar M; Padma MR; Unnikrishnan KP; Rajesh J; Kumar P; Sahu S; Wares F; Floyd K
    Int J Tuberc Lung Dis; 2009 Jun; 13(6):705-12. PubMed ID: 19460245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Outcomes and problems of DOTS strategy in Japan].
    Ahiko T
    Kekkaku; 2007 Feb; 82(2):119-23. PubMed ID: 17373322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review series: the politics of TB: the politics, economics and impact of directly observed treatment (DOT) in India.
    Udwadia ZF; Pinto LM
    Chron Respir Dis; 2007; 4(2):101-6. PubMed ID: 17621578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.